17856-1133-4 : NDC 2026 Code

17856-1133-4 : Spironolactone ( Spironolactone )

Additionally :

You can get information about “17856-1133-4” NDC code in 17856-1133-4 in HTML format

HTML | 17856-1133-4 in TXT (Plain Text) format

TXT | 17856-1133-4 in PDF (Portable Document Format)

PDF | 17856-1133-4 in XML format

XML formats.

NDC Code : 17856-1133-4 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "17856-1133-4",
    "PackageDescription": "1 SYRINGE in 1 BAG (17856-1133-4)  / 2.5 mL in 1 SYRINGE",
    "NDC11Code": "17856-1133-04",
    "ProductNDC": "17856-1133",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Spironolactone",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Spironolactone",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20231031",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA AUTHORIZED GENERIC",
    "ApplicationNumber": "NDA209478",
    "LabelerName": "ATLANTIC BIOLOGICALS CORP.",
    "SubstanceName": "SPIRONOLACTONE",
    "StrengthNumber": "25",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-09-30",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250926",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}